HEMEX expands to China

On 14th November 2019, our CEO Pascal Winnen signed a cooperation agreement with the Luoyang Science and Innovation Park in Henan, China’s most populated province.

Under the Agreement, HEMEX will support the property developer Forton Group with attracting innovative Swiss startups for its newly built 133’000 m2 life science park. In exchange, HEMEX and its clients will get access to Henan’s 108 million population to conduct clinical trials and receive governmental support to accelerate preclinical and clinical development projects, as well as granted access to significant non-dilutive research funding.

A big thank you to Dr. Robert Sum of the Standortförderung BL for leading this very efficient economic mission.


Leave a Reply

Your email address will not be published. Required fields are marked *